Evidence map›Paper›PMID 41553244›Full record

ArticleThe Analyst2026

Evaluation of ToF-SIMS imaging for semi-quantitative mapping of BODIPY-labeled fibronectin surface gradients.

Chao Liu, Tae Kyong John Kim, Douglas H Wu, Radhika Atit, Rodrigo A Somoza, Samuel E Senyo

Abstract read
In one paragraph

Article in The Analyst, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chao LiuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. ssenyo@case.edu.ORCID http://orcid.org/0000-0003-3227-6813
Tae Kyong John KimSwagelok Center for Surface Analysis of Materials, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-0748-7929
Douglas H WuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. ssenyo@case.edu.ORCID http://orcid.org/0000-0002-5018-4106
Radhika AtitDepartment of Biology, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-3492-6552
Rodrigo A SomozaDepartment of Biology, Skeletal Research Center, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-8050-357X
Samuel E SenyoDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. ssenyo@case.edu.ORCID http://orcid.org/0000-0002-9206-6845

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)UM1TR004528 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI GRACE A MCCOMSEY · 2023 to 2026
$32.1M
TR&D-4: Growing Tissue in the Scalable, Modular, Automated, and Closed (SMAC) FoundryP41EB021911 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI JEAN F WELTER · 2016 to 2026
$13.9M
Interdisciplinary Biomedical Imaging Training ProgramT32EB007509 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI DAVID Lynn WILSON, Xin Yu · 2007 to 2026
$5.6M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Study of AR transcriptional network in stem cell model of SBMAR01NS121374 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI MIRANDA, HELEN C · 2021 to 2025
$2.0M
Substrate-mediated collective cell migration incalvarial bone expansion and disease.R01DE032670 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI RADHIKA P ATIT, Matthew P Harris · 2024 to 2026
$2.0M
Substrate-mediated collective cell migration in calvarial bone expansion and diseaseR56DE030206 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI ATIT, RADHIKA P, HARRIS, MATTHEW P · 2021 to 2021
$571k
NCATS NIH HHS TL1 TR002549NCATS NIH HHS UM1 TR004528NIBIB NIH HHS P41 EB021911NIBIB NIH HHS T32 EB007509NIDCR NIH HHS R01 DE032670NIDCR NIH HHS R56 DE030206NIGMS NIH HHS T32 GM007250NINDS NIH HHS R01 NS121374
6 · The paper itself

Abstract

Microfluidic platforms offer controlled microenvironments for studying cell migration such as haptotaxis. In many gradient-based assays, protein gradients are first visualized using higher concentrations of fluorescent labels, since gradients formed at biologically relevant ligand densities often fall below the detection limits of conventional imaging methods. In this study, we demonstrate the feasibility of characterizing fibronectin gradients using a more sensitive, high-resolution approach with Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS). Our methods increase analytical sensitivity to fibronectin gradients formed on commonly used synthetic surfaces to better elucidate physiological mechanisms and ensure experimental reproducibility. We utilized a microfluidic chip with a silicone housing placed on an optically clear plastic microscope slide designed for live-cell microscopy. Slides were coated with fibronectin incorporating surrogate labels for ToF-SIMS analysis to investigate spatial distribution. To enhance signal detection, fibronectin was labeled or conjugated with copper, bromine, and fluorine-containing BODIPY as surrogate elements. Among the tested labels, BODIPY-fibronectin (BODIPY-FN) provided the lowest background signal, enabling fluorescence-based detection at concentrations of 10 µg mL

Indexed as

Boron CompoundsFibronectinsFluorescent DyesSpectrometry, Mass, Secondary IonAnimalsHumansMicrofluidic Analytical TechniquesSurface Properties4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsFibronectinsFluorescent Dyes

Identifiers

PMID41553244
PMCPMC12814933

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.